• Users Online: 67
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most popular articles (Since November 01, 2017)

 
 
  Archives   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ABSTRACTS
Dietary assessment methods
Khor Ban Hock, Dina Tallman, Deepinder Kaur, Zulfitri ‘Azuan Mat Daud, Pramod Khosla, Tilakavati Karupaiah
January-March 2018, 3(1):8-8
DOI:10.4103/2395-1540.232539  
  272 78 -
WORKSHOP PROGRAM
Workshop on nutritional screening and assessment

January-March 2018, 3(1):1-1
  236 64 -
ABSTRACTS
The Nutrition Care Process model (NCPM) for patients with Chronic Kidney Disease (CKD)
Tilakavati Karupaiah
January-March 2018, 3(1):6-6
DOI:10.4103/2395-1540.232537  
  205 69 -
Limited (ISAK) profiling The International Society for the Advancement of Kinanthropometry (ISAK)
Tilakavati Karupaiah
January-March 2018, 3(1):11-11
DOI:10.4103/2395-1540.232541  
  195 51 -
Bioelectrical impedance analysis (BIA)
Sharmela Sahathevan, Khor Ban Hock, Zulfitri Azuan Mat Daud, Tilakavati Karupaiah
January-March 2018, 3(1):12-12
DOI:10.4103/2395-1540.232542  
  189 55 -
Assessing nutritional status – Quick tools
Sharmela Sahathevan, Khor Ban Hock, Zulfitri ‘Azuan Mat Daud, Tilakavati Karupaiah
January-March 2018, 3(1):9-10
DOI:10.4103/2395-1540.232540  
  170 58 -
Restless leg syndrome
Deepinder Kaur, Dina Tallman, Pramod Khosla
January-March 2018, 3(1):14-14
DOI:10.4103/2395-1540.232544  
  158 54 -
MESSAGES
Message
AK Bhalla
January-March 2018, 3(1):3-3
DOI:10.4103/2395-1540.232547  
  170 42 -
ABSTRACTS
Nutrition assessment for patients with Chronic Kidney Disease (CKD)
Zulfitri ‘Azuan Mat Daud
January-March 2018, 3(1):7-7
DOI:10.4103/2395-1540.232538  
  143 59 -
WORKSHOP PROGRAM
Day 2 - Patch program

January-March 2018, 3(1):2-2
  150 41 -
MESSAGES
Message
Anita Saxena
January-March 2018, 3(1):4-4
DOI:10.4103/2395-1540.232546  
  144 34 -
Workshop on nutritional screening and assessment
Tilakavati Karupaiah
January-March 2018, 3(1):5-5
DOI:10.4103/2395-1540.232548  
  135 42 -
ABSTRACTS
Questionnaire validation in dietary studies
Karuthan Chinna
January-March 2018, 3(1):15-15
DOI:10.4103/2395-1540.232545  
  117 37 -
Frailty
Dina Tallman, Deepinder Kaur, Pramod Khosla
January-March 2018, 3(1):13-13
DOI:10.4103/2395-1540.232543  
  89 37 -
REVIEW ARTICLES
How to provide very low protein diet
Zamurudin Patel
April-June 2018, 4(2):23-25
DOI:10.4103/2395-1540.246996  
  87 26 -
ARTICLE
Concept of brain death
UK Mishra
April-June 2016, 2(2):12-12
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  91 21 -
CASES ON ORGAN DONATION
Transplant coordinator's role in cadaveric organ donation
Pallavi Kumar, Sumana Navin
April-June 2016, 2(2):14-16
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  74 18 -
ARTICLE
Importance of universal precautions in HIV, HBV, HCV positive patients
DK Sinha
April-June 2016, 2(2):5-7
Universal precautions (UP) are control guidelines designed to protect Health Care workers (HCW) from exposure to iseases spread by blood and other body fluids. This article reviews universal precautions include, hand washing, decontamination of equipment and devices , use and disposal of needles and sharps safely (no recapping), wearing protective items, prompt cleaning up of blood and body fluid spills, systems for safe collection of waste and disposal. All health care workers must learn the importance of good hygiene and hand washing techniques. Consider every patient as a potent source of infection unless proved otherwise. Despite increasing medical facilities, risk of acquiring infection by both patients and health care worker (HCW) from each other remains high in a health care setup 1 Hospital acquired infections (HAI) are an important cause of death globally. A variety of different microbes (commensals, pathogenic bacteria, viruses, parasites, and fungi) cause HAI among HCW. HIV, hepatitis B, and hepatitis C are the most frequently acquired infections. The term ‘universal precautions’ has been replaced by the term ‘Standard precautions’. These are designed to reduce the risk of transmission of microorganisms in health care set-up and reduce morbidity. This article reviews the standard precautions for minimizing HAI2,3.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  66 21 -
ORIGINAL ARTICLE
Efficacy and safety of gliptins in patients with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Mita B Shah, Prashant Rajput, Bharat V Shah
April-June 2016, 2(2):2-4
Introduction: Gliptins are a new class of oral hypoglycemic agents that inhibit Dipeptidyl peptidase-4 (DPP– 4) and improve glycemic control through enhancement of the incretin axis. They are not associated with hypoglycemia and they do not cause weight gain. However, there is no Indian study about the efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). The aim of the study was to determine the efficacy and safety of gliptins in patients with T2DM and CKD. Methods: Twenty nine (Male 17 and female 12) patients with T2DM and CKD (creatinine clearance < 60 ml/min) were included in the study. These subjects were started on gliptin for increasing number of hypoglycemia episodes with existing therapy (insulin and/or secretogogue). With introduction of gliptin, the dose of existing antihyperglycemic therapy was reduced. All these patients were followed for a minimum period of 6 months. The glycemic control, number of hypoglycemic episodes, weight and creatinine clearance were monitored. Results: The mean (SD) age of study subjects was 64 (11) years. The mean (SD) HBA1 c at the start of gliptin was 8.1 (1.4). After 6 months it was 7.9 (1.5). There was only 1 episode of hypoglycemia in 1 patient. The mean (SD) weight before the start of gliptin was 72.3 (10.6) kg and 6 months later it was 71.9 (10.9) kg. The mean (SD) creatinine clearance at the time of introducing gliptin was 29 (12) ml/min. After 6 months it was 28 (13) ml/min. All patients tolerated gliptin well and there was no adverse effect in any patient. Conclusion: Gliptins are effective hypoglycemic agents for T2DM with CKD. They are not associated with hypoglycemic episodes, do not cause weight gain and are well tolerated.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  61 25 -
MESSAGE
Message
Umesh Khanna, Zamurrud Patel, Shruti Tapiawala
April-June 2018, 4(2):21-21
DOI:10.4103/2395-1540.247006  
  62 18 -
REVIEW ARTICLES
Impact of kidney disease on nutrition
Shruti Tapiawala
April-June 2018, 4(2):30-34
DOI:10.4103/2395-1540.247004  
  63 16 -
ARTICLE
ABO incompatible kidney transplantation
AK Bhalla
April-June 2016, 2(2):17-18
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  55 19 -
EDITORIAL
Gleptins

April-June 2016, 2(2):1-1
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  48 26 -
ARTICLE
Counselling for renal replacement therapy
Archana Bhadauria
April-June 2016, 2(2):8-11
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  55 18 -
ABSTRACT
Advising diet for dialysis patients
Poonam Tiwari
April-June 2016, 2(2):21-21
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  49 19 -